Figure 7From: Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor Erythropoietin (EPO) administration enhances the expression of the erythropoietin receptor (EpoR) in the brainstem of traumatic axonal injury with hypoxia (TAI + Hx) rats. (A) In the corpus callosum, TAI rats had a significant elevation in EpoR numbers over sham at 1,7 and 14 days, with similar numbers observed in TAI + EPO rats over this time course. (B) TAI + Hx and TAI + Hx + EPO treatments both resulted in increased numbers of positive cells at 1 day compared to sham, with both groups peaking at 7 days before returning to sham levels at 14 days. (C) TAI and TAI + EPO rats showed a similar expression pattern of EpoR in the brainstem at 1 d, however at 7 d, TAI + EPO rats had a substantial increase in the number of cells staining positively for EpoR. (D) No increase in EpoR positive cells was observed in the pyramidal tracts at 1 d after TAI + Hx; however in these rats, EPO administration induced a significant increase in EpoR expression. At 7 d, the number of EpoR-positive cells increased in TAI + Hx similarly to TAI + Hx + EPO. Letters matched to letter with apostrophe indicate a significant difference, P <0.05; 2-way ANOVA with post-hoc Bonferroni test. Data expressed as mean ± SEM, n = 6/group. *(E) Photomicrograph demonstrating low level of EpoR expression in the pyramidal tracts after sham surgery, a mild increase in TAI + Hx (F), and a significant increase in EpoR-positive cells in TAI + Hx + EPO rats (G). Scale bar = 100 μm.Back to article page